survey linear regressions were used to analyze prevalence of DAH using the different guidelines controlling for race and sex. Predictors of depression were analyzed using survey logistic regression models. Results: Preliminary analysis shows that the overall unadjusted prevalence of DAH was 62.8%. The unadjusted prevalence of DAH was found to be 64% using the JNC 7 guideline and 62% using the 2017 ACC/AHA guideline. Further analysis and adjusting for age, race/ethnicity and sex shows that the prevalence of DAH is significantly lower in the 2017 ACC/AHA guideline compared to the JNC 7 guideline by nearly 2.15%. There was also a decrease in the unadjusted and adjusted prevalence of DAH after applying the guidelines among all race/ethnicities and by sex, with the use of older guideline resulting in a greater prevalence of depression. Conclusions: With the change in the guidelines for measurement and diagnosis of hypertension, there was significant decrease in the prevalence of DAH. The distribution of the prevalence of DAH between hypertension categories also changed with the current guidelines. Further research into effective screening and management for depression, and future longitudinal follow-up of this population is needed.
Introduction: The World Stroke Organization (WSO) Brain & Heart Task Force developed the Brain & hEart globAl iniTiative (BEAT), a pilot feasibility implementation program to establish clinical collaborations between cardiologists and stroke physicians who work at large healthcare facilities. Methods: The WSO BEAT pilot project focused on atrial fibrillation (AF) and patent foramen ovale (PFO) detection and management, and poststroke cardiovascular complications known as the stroke-heart syndrome. The program included 10 sites from 8 countries: Brazil, China, Egypt, Germany, Japan, Mexico, Romania, and the USA The primary composite feasibility outcome was the achievement of the following 3 implementation metrics (1) developing site-specific clinical pathways for the diagnosis and management of AF, PFO, and the stroke-heart syndrome; (2) establishing regular Neurocardiology rounds (e.g., monthly); and (3) incorporating a cardiologist to the stroke team. The secondary objectives were (1) to identify implementation challenges to guide a larger program and (2) to describe qualitative improvements. Results: The WSO BEAT pilot feasibility program achieved the prespecified primary composite outcome in 9 of 10 (90%) sites. The most common challenges were the limited access to specific medications (e.g., direct oral anticoagulants) and diagnostic (e.g., prolonged cardiac monitoring) or therapeutic (e.g., PFO closure devices) technologies. The most relevant qualitative improvement was the achievement of a more homogeneous diagnostic and therapeutic approach. Conclusion: The WSO BEAT pilot program suggests that developing neurocardiology collaborations is feasible. The long-term sustainability of the WSO BEAT program and its impact on quality of stroke care and clinical outcomes needs to be tested in a larger and longer duration program.
s133hospital admissions (0.98; 0.96-0.99). No difference was observed among admissions for ACSCs. ConClusions: These findings suggest MH healthcare is associated with improvements in healthcare utilization rates. Additional healthcare utilization outcomes should be evaluated and further longitudinal analyses, including adjustments for other potential confounders, should be conducted as more MHs are implemented and additional years' data become available.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.